| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.5 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.5 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.035 | 0.5 |